Mechanisms of development of constipation in Parkinson’s disease and therapeutic approaches

Close metadata

Recommended articles:

Criteria of syndrome frailty in Parkinson´s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):52-56

Promising approaches to the pathogenetic therapy of amyotrophic lateral sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):13-21

Tremor-dominant form of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):28-35

Nocturia in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):48-54

Molecular Genetic Aspects of Varicose Vein Disease: Modern Concepts. Journal of Venous Disorders. 2024;(1):48-53

Genetic factors in degenerative disc disease. Burdenko's Journal of Neurosurgery. 2024;(2):112-118

Pathogenetic, clinical-diagnostic and therapeutic aspects of premenstrual syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):37-42

Morphological features of vasoproliferative tumor of the retina. Russian Journal of Archive of Pathology. 2024;(2):42-50

Traumatic damage to the diaphragm in children. Pirogov Russian Journal of Surgery. 2024;(4):64-68

Clinical and morphological assessment of patients with adenomyosis: own data. Russian Journal of Human Reproduction. 2024;(2):130-135

Constipation is one of the most common non-motor symptoms of Parkinson’s disease. The pathogenetic mechanisms of constipation, diagnostic criteria, approaches to investigations and treatment are discussed in the paper.

Keywords:

Parkinson’s disease

constipation

pathogenesis

treatment

Authors:

Katunina E.A.

Federal Center of Brain and Neurotechnologies;
Pirogov Russian National Research Medical University

ORCID: 0000-0001-5805-486X

Shipilova N.N.

Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation

Katunin D.A.

Pirogov Russian National Research Medical University;
Federal Center for Brain and Neurotechnologies

Received:

09.03.2022

Accepted:

15.03.2022

List of references:

Balestrino R, Martinez-Martin P. Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson’s disease. Journal of the Neurological Sciences. 2017;373:173-178. https://doi.org/10.1016/j.jns.2016.12.060
Sharma A, Kurek J, Morgan J, Wakade C, Rao S. Constipation in Parkinson’s Disease: a Nuisance or Nuanced Answer to the Pathophysiological Puzzle? Curr Gastroenterol Rep. 2018;20(1):1. https://doi.org/10.1007/s11894-018-0609-x
Stirpe P, Hoffman M, Badiali D, Colosimo C. Constipation: an emerging risk factor for Parkinson’s disease? Eur J Neurol. 2016;23:1606-1613. https://doi.org/10.1111/ene.13082
Fasano A, Visanji N, Liu L, et al. Gastrointestinal dysfunction in Parkinson’s disease. The Lancet Neurology. 2015;14:625-639. https://doi.org/10.1016/s1474-4422(15)00007-1
Chen H, Zhao E, Zhang W, et al. Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis. Transl Neurodegener. 2015;4(1):1. https://doi.org/10.1186/2047-9158-4-1
Sakakibara R, Odaka T, Uchiyama T, et al. Colonic transit time and rectoanal videomanometry in Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 2003;74:268-272. https://doi.org/10.1136/jnnp.74.2.268
Longstreth G, Thompson W, Chey W, et al. Functional Bowel Disorders. Gastroenterology. 2006;130(5):1480-1491. https://doi.org/10.1053/j.gastro.2005.11.061
Cersosimo M, Raina G, Pecci C, et al. Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptoms. J Neurol. 2012;260:1332-1338. https://doi.org/10.1007/s00415-012-6801-2
Edwards L, Pfeiffer R, Quigley E, et al. Gastrointestinal symptoms in Parkinson’s disease. Movement Disorders. 1991;6:151-156. https://doi.org/10.1002/mds.870060211
Chaudhuri K, Martinez-Martin P, Schapira A, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: The NMSQuest study. Movement Disorders. 2006;21:916-923. https://doi.org/10.1002/mds.20844
Korczyn AD. Autonomic nervous system disturbances in Parkinson’s disease. Adv Neurol. 1990;53:463-468.
Lin C, Lin J, Liu Y, et al. Risk of Parkinson’s disease following severe constipation: A nationwide population-based cohort study. Parkinsonism Relat Disord. 2014;20(12):1371-1375. https://doi.org/10.1016/j.parkreldis.2014.09.026
Sung H, Park J, Kim J. The Frequency and Severity of Gastrointestinal Symptoms in Patients with Early Parkinson’s Disease. J Mov Disord. 2014;7(1):7-12. https://doi.org/10.14802/jmd.14002
Picillo M, Amboni M, Erro R, et al. Gender differences in non-motor symptoms in early, drug naïve Parkinson’s disease. J Neurol. 2013;260(11):2849-2855. https://doi.org/10.1007/s00415-013-7085-x
Kim H, Park S, Cho Y, et al. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci. 2009;287(1-2):200-204. https://doi.org/10.1016/j.jns.2009.07.026
Pont-Sunyer C, Hotter A, Gaig C, et al. The Onset of Nonmotor Symptoms in Parkinson’s disease (The ONSET PDStudy). Movement Disorders. 2015;30(2):229-237. https://doi.org/10.1002/mds.26077
Krogh K, Ostergaard K, Sabroe S, Laurberg S. Clinical aspects of bowel symptoms in Parkinson’s disease. Acta Neurol Scand. 2008;117:60-64. https://doi.org/10.1111/j.1600-0404.2007.00900.x
Visser M, Marinus J, Stiggelbout A, Van Hilten J. Assessment of autonomic dysfunction in Parkinson’s disease: The SCOPA-AUT. Movement Disorders. 2004;19:1306-1312. https://doi.org/10.1002/mds.20153
Szewczyk-Krolikowski K, Tomlinson P, Nithi K, et al. The influence of age and gender on motor and non-motor features of early Parkinson’s disease: Initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord. 2014;20:99-105. https://doi.org/10.1016/j.parkreldis.2013.09.025
Sakakibara R, Shinotoh H, Uchiyama T et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson’s disease. Autonomic Neuroscience. 2001;92:76-85. https://doi.org/10.1016/s1566-0702(01)00295-8
Zibetti M, Torre E, Cinquepalmi A, et al. Motor and Nonmotor Symptom Follow-Up in Parkinsonian Patients after Deep Brain Stimulation of the Subthalamic Nucleus. Eur Neurol. 2007;58:218-223. https://doi.org/10.1159/000107943
Gaenslen A, Swid I, Liepelt-Scarfone I, et al. The patients’ perception of prodromal symptoms before the initial diagnosis of Parkinson’s disease. Movement Disorders. 2011;26:653-658. https://doi.org/10.1002/mds.23499
Santos-García D, de la Fuente-Fernández R. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson’s disease. J Neurol Sci. 2013;332:136-140. https://doi.org/10.1016/j.jns.2013.07.005
Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Movement Disorders. 2009;24:1641-1649. https://doi.org/10.1002/mds.22643
Edwards L, Quigley E, Hofman R, Pfeiffer R. Gastrointestinal symptoms in parkinson disease: 18-month follow-up study. Movement Disorders. 1993;8:83-86. https://doi.org/10.1002/mds.870080115
Neikrug A, Avanzino J, Liu L, et al. Parkinson’s disease and REM sleep behavior disorder result in increased non-motor symptoms. Sleep Med. 2014;15:959-966. https://doi.org/10.1016/j.sleep.2014.04.009
Giorelli M, Bagnoli J, Consiglio L, et al. Change in non-motor symptoms in Parkinson’s disease and essential tremor patients: a one-year follow-up study. Tremor Other Hyperkinet Mov (N Y). 2014;4:216. https://doi.org/10.7916/D82J68TH
Spica V, Pekmezović T, Svetel M, Kostić V. Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson’s disease. J Neurol. 2013;260:131-137. https://doi.org/10.1007/s00415-012-6600-9
Khoo T, Yarnall A, Duncan G, et al. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology. 2013;80:276-281. https://doi.org/10.1212/wnl.0b013e31827deb74
Khedr E, El Fetoh N, Khalifa H, et al. Prevalence of non motor features in a cohort of Parkinson’s disease patients. Clin Neurol Neurosurg. 2013;115:673-677. https://doi.org/10.1016/j.clineuro.2012.07.032
Crosiers D, Pickut B, Theuns J, et al. Non-motor symptoms in a Flanders-Belgian population of 215 Parkinson’s disease patients as assessed by the Non-Motor Symptoms Questionnaire. Am J Neurodegener Dis. 2012;1:160-167.
Martinez-Martin P, Schapira A, Stocchi F, et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients. Movement Disorders. 2007;22:1623-1629. https://doi.org/10.1002/mds.21586
Verbaan D, Marinus J, Visser M, et al. Patient-reported autonomic symptoms in Parkinson disease. Neurology. 2007;69:333-341. https://doi.org/10.1212/01.wnl.0000266593.50534.e8
Siddiqui M, Rast S, Lynn M, et al. Autonomic dysfunction in Parkinson’s disease: a comprehensive symptom survey. Parkinsonism Relat Disord. 2002;8:277-284. https://doi.org/10.1016/s1353-8020(01)00052-9
Yu B, Xiao ZY, Li JZ, et al. Study of an integrated non-motor symptoms questionnaire for Parkinson’s disease. Chin Med J. 2010;123:1436-1440.
Rodríguez-Violante M, de Saráchaga A, Cervantes-Arriaga A, et al. Self-Perceived Pre-Motor Symptoms Load in Patients with Parkinson’s Disease: A Retrospective Study. J Parkinsons Dis. 2016;6:183-190. https://doi.org/10.3233/jpd-150705
Postuma R, Adler C, Dugger B, et al. REM sleep behavior disorder and neuropathology in Parkinson’s disease. Movement Disorders. 2015;30:1413-1417. https://doi.org/10.1002/mds.26347
Fereshtehnejad S, Romenets S, Anang J, et al. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression. JAMA Neurol. 2015;72:863. https://doi.org/10.1001/jamaneurol.2015.0703
Kashihara K, Imamura T, Shinya T. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson’s disease. Parkinsonism Relat Disord. 2010;16:252-255. https://doi.org/10.1016/j.parkreldis.2009.12.010
Martinez-Martin P, Falup Pecurariu C, Odin P, et al. Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease. J Neurol. 2012;259:1639-1647. https://doi.org/10.1007/s00415-011-6392-3
Forjaz M, Ayala A, Rodriguez-Blazquez C, Frades-Payo B, Martinez-Martin P. Assessing autonomic symptoms of Parkinson’s disease with the SCOPA-AUT: a new perspective from Rasch analysis. Eur J Neurol. 2010;17(2):273-279. https://doi.org/10.1111/j.1468-1331.2009.02835.x
Chaudhuri K, Martinez-Martin P, Brown R, et al. The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: Results from an international pilot study. Movement Disorders. 2007;22(13):1901-1911. https://doi.org/10.1002/mds.21596
Edwards L, Quigley E, Harned R, Hofman R, Pfeiffer R. Characterization of swallowing and defecation in Parkinson’s disease. Am J Gastroenterol. 1994;89:15-25.
Jost W, Schrank B. Defecatory disorders in de novo Parkinsonians—colonic transit and electromyogram of the external anal sphincter. Wien Klin Wochenschr. 1998;110(15):535-537.
Cersosimo M, Benarroch E. Neural control of the gastrointestinal tract: Implications for Parkinson disease. Movement Disorders. 2008;23(8):1065-1075. https://doi.org/10.1002/mds.22051
Jost W, Schimrigk K. Constipation in Parkinson’s disease. Klin Wochenschr. 1991;69:906-909. https://doi.org/10.1007/bf01798536
Ashraf W, Pfeiffer R, Park F, et al. Constipation in parkinson’s disease: Objective assessment and response to psyllium. Movement Disorders. 1997;12(6):946-951. https://doi.org/10.1002/mds.870120617
Shannon K, Keshavarzian A, Mutlu E, et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson’s disease. Movement Disorders. 2012;6:709-715. https://doi.org/10.1002/mds.23838
Visanji N, Brooks P, Hazrati L, Lang A. The prion hypothesis in Parkinson’s disease: Braak to the future. Acta Neuropathol Commun. 2013;1:2. https://doi.org/10.1186/2051-5960-1-2
Beach T, Adler C, Sue L, et al. Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2009;119:689-702. https://doi.org/10.1007/s00401-010-0664-3
Braak H, Del Tredici K, Bratzke H, et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol. 2002;249(3):1-5. https://doi.org/10.1007/s00415-002-1301-4
Gai W, Blumbergs P, Geffen L, Blessing W. Age-related loss of dorsal vagal neurons in Parkinson’s disease. Neurology. 1992;42:2106-2111. https://doi.org/10.1212/wnl.42.11.2106
Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease—the gut-brain axis and environmental factors. Nature Reviews Neurology. 2015;11(11):625-636. https://doi.org/10.1038/nrneurol.2015.197
Pan-Montojo F, Schwarz M, Winkler C, et al. Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice. Sci Rep. 2012;2:898. https://doi.org/10.1038/srep00898
Holmqvist S, Chutna O, Bousset L, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128:805-820. https://doi.org/10.1007/s00401-014-1343-6
Svensson E, Horváth-Puhó E, Thomsen R, et al. Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol. 2015;78:522-529. https://doi.org/10.1002/ana.24448
Braak H, Sastre M, Bohl J, de Vos R, Del Tredici K. Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol. 2007;113:421-429. https://doi.org/10.1007/s00401-007-0193-x
Phillips R, Powley T. Innervation of the gastrointestinal tract: Patterns of aging. Autonomic Neuroscience. 2007;136:1-19. https://doi.org/10.1016/j.autneu.2007.04.005
Wade P, Hornby P. Age-Related Neurodegenerative Changes and How They Affect the Gut. Science of Aging Knowledge Environment. 2005;2005(12):pe8. https://doi.org/10.1126/sageke.2005.12.pe8
Wakabayashi K, Takahashi H, Ohama E, et al. Lewy bodies in the visceral autonomic nervous system in Parkinson’s disease. Advances in Neurology. 1993;60:609-612.
Andersson K. Mechanisms of Disease: central nervous system involvement in overactive bladder syndrome. Nature Clinical Practice Urology. 2004;1(2):103-108. https://doi.org/10.1038/ncpuro0021
Petrovitch H, Abbott R, Ross G, et al. Bowel movement frequency in late-life and substantia nigra neuron density at death. Movement Disorders. 2009;24:371-376. https://doi.org/10.1002/mds.22360
Hinkle J, Perepezko K, Mills K, et al. Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease. Parkinsonism Relat Disord. 2018;55:8-14. https://doi.org/10.1016/j.parkreldis.2018.08.010
Derkinderen P, Shannon K, Brundin P. Gut feelings about smoking and coffee in Parkinson’s disease. Movement Disorders. 2014;29:976-979. https://doi.org/10.1002/mds.25882
Houser M, Chang J, Factor S, et al. Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson’s Disease. Movement Disorders. 2018;33:793-804. https://doi.org/10.1002/mds.27326
Brudek T. Inflammatory Bowel Diseases and Parkinson’s Disease. J Parkinsons Dis. 2019;9(s2):331-344. https://doi.org/10.3233/jpd-191729
Lin J, Lin C, Hsu C, Lin C, Kao C. Association Between Parkinsonʼs Disease and Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016;22(5):1049-1055. https://doi.org/10.1097/mib.0000000000000735
Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T. Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977—2014. Gut. 2018;68(1):18-24. https://doi.org/10.1136/gutjnl-2017-315666
Klegeris A, Giasson B, Zhang H, et al. Alpha‐synuclein and its disease‐causing mutants induce ICAM‐1 and IL‐6 in human astrocytes and astrocytoma cells. The FASEB Journal. 2006;20:2000-2008. https://doi.org/10.1096/fj.06-6183com
McGeer P, McGeer E. The α-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease. Exp Neurol. 2008;212:235-238. https://doi.org/10.1016/j.expneurol.2008.04.008
Hunot S, Dugas N, Faucheux B, et al. FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces,In Vitro,Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells. The Journal of Neuroscience. 1999;19:3440-3447. https://doi.org/10.1523/jneurosci.19-09-03440.1999
Villarán R, Espinosa-Oliva A, Sarmiento M, et al. Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease. J Neurochem. 2010;114(6):1687-1700. https://doi.org/10.1111/j.1471-4159.2010.06879.x
Kellow J, Gill R, Wingate D. Modulation of human upper gastrointestinal motility by rectal distension. Gut. 1987;28:864-868. https://doi.org/10.1136/gut.28.7.864
Astarloa R, Mena M, Sánchez V, et al. Clinical and Pharmacokinetic Effects of a Diet Rich in Insoluble Fiber on Parkinson Disease. Clin Neuropharmacol. 1992;15:375-380. https://doi.org/10.1097/00002826-199210000-00004
Ashraf W, Wszolek Z, Pfeiffer R, et al. Anorectal function in fluctuating (on-off) Parkinson’s disease: Evaluation by combined anorectal manometry and electromyography. Movement Disorders. 1995;10(5):650-657. https://doi.org/10.1002/mds.870100519
Su A, Gandhy R, Barlow C, Triadafilopoulos G. Utility of high-resolution anorectal manometry and wireless motility capsule in the evaluation of patients with Parkinson’s disease and chronic constipation. BMJ Open Gastroenterol. 2016;3(1):e000118. https://doi.org/10.1136/bmjgast-2016-000118
Rao S. Dyssynergic Defecation and Biofeedback Therapy. Gastroenterol Clin North Am. 2008;37(3):569-586. https://doi.org/10.1016/j.gtc.2008.06.011
Mathers S, Kempster P, Law P, et al. Anal Sphincter Dysfunction in Parkinson’s Disease. Arch Neurol. 1989;46:1061-1064. https://doi.org/10.1001/archneur.1989.00520460037010
Sakakibara R, Uchiyama T, Yamanishi T, et al. Bladder and bowel dysfunction in Parkinson’s disease. J Neural Transm. 2008;115(3):443-460. https://doi.org/10.1007/s00702-007-0855-9
Del Tredici K, Rüb U, de Vos R, et al. Where Does Parkinson Disease Pathology Begin in the Brain? Journal of Neuropathology & Experimental Neurology. 2002;61(5):413-426. https://doi.org/10.1093/jnen/61.5.413
Albanese A, Brisinda G, Bentivoglio A, Maria G. Treatment of Outlet Obstruction Constipation in Parkinson’S Disease With Botulinum Neurotoxin A. American Journal of Gastroenterology. 2003;98(6):1439-1440. https://doi.org/10.1111/j.1572-0241.2003.07514.x

Close metadata